Discover what EASL is, what EASL does, why EASL exists, and find out who works behind the scenes at EASL.
How can EASL support your liver research?Find out about the different EASL programs, events, and tools that will take your understanding of the liver to a new level.
The EASL Fellowship programmes, aim to enhance the mobility of investigators within different European institutions by actively promoting scientific exchange among research units in Hepatology.
This programme is based on establishing ongoing relationships. Mentorship enables informal transmission of knowledge and is a means of support for the mentee’s work, career, and professional development.
As a major European Association dedicated to the liver and liver disease, EASL promotes research and education through the sharing of research findings in Hepatology.
They define the use of diagnostic, therapeutic and preventive modalities, including non-invasive and invasive procedures, in the management of patients with various liver diseases.
The Journal of Hepatology is the official journal of EASL publishing original papers, reviews and letters to the editor concerned with clinical and basic research in the field of Hepatology.
Liver disease: a complex matter.A range of illnesses can affect and damage the liver - explore them here.
EASL supports Young Investigators by attributing 200 travel bursaries each year together with one year’s free EASL Membership to the presenting authors of the best scored abstracts.
Every year EASL hosts three schools for young hepatologists which provide teaching in an intimate environment to facilitate exchange between expert and trainee.
This new educational platform centralizes and organizes thousands of EASL educational materials published over the past eight years.
EASL online education allows you to continue learning over a variety of platforms.
Extend your knowledge of the liver with EASL support and continuous learning opportunities.
In an era where practice in hepatology has been revolutionised by an avalanche of therapeutic breakthroughs, hepatocellular carcinoma (HCC) still …
In a keynote speech given at the International Liver Congress in …
At the 2017 International Liver Congress™ in Amsterdam, The Netherlands, …
On behalf of the European Association for the Study of the Liver (EASL), we are delighted to welcome you …
Human infectious disease affecting the liver caused by an RNA virus from the Flaviviridae family, the hepatitis C virus.